Steady-State Feedback Actions of Testosterone on Luteinizing Hormone Secretion in Young and Older Men
NCT00431197 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2010-01-28
Summary
This study is being done to learn how the male hormone , testosterone, affects pituitary hormones in younger and older men. The pituitary is a gland in the brain that secretes hormones, some of which normally control growth and fertility.
Conditions
- Hypogonadism
Interventions
- DRUG
-
Ketoconazole, Dexamethesone, Androgel,GnRH
Sponsors & Collaborators
-
National Institutes of Health (NIH)
collaborator NIH - lead OTHER
Principal Investigators
-
Johannes D. Veldhuis, M.D. · Mayo Clinic
Study Design
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2004-02-29
- Primary Completion
- 2007-12-31
- Completion
- 2007-12-31
Countries
- United States
Study Locations
More Related Trials
-
Efficacy, Pharmacokinetics and Safety of Testosterone
NCT01370369 ·Status: COMPLETED ·Phase: PHASE2
-
Single-Dose Pharmacokinetics of Oral Testosterone Undecanoate With and Without Concomitant Inhibition of UGT2B17
NCT06312761 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Safety of Subcutaneous Testosterone Enanthate in Adult Male Hypogonadism
NCT02777242 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Mixed Exercise and Metabolic Stress in Relationship to Age in Healthy Men
NCT01800370 ·Status: COMPLETED ·Phase: PHASE1
-
Oral Androgens in Man-3 (ORAL T-3) Pharmacokinetics of Oral Testosterone
NCT00161421 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Varying Testosterone Levels on Insulin Sensitivity in Men With Idiopathic Hypogonadotropic Hypogonadism (IHH)
NCT03118479 ·Status: TERMINATED ·Phase: PHASE1
-
Does Testosterone Improve Function in Hypogonadal Older Men
NCT00304213 ·Status: WITHDRAWN ·Phase: PHASE4
-
Testosterone Treatment for Hypogonadal Men
NCT00433199 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter Extension Trial to Evaluate the Safety of Testosterone Gel
NCT01703741 ·Status: COMPLETED ·Phase: PHASE3
-
ITT4 Intratesticular Hormonal Milieu in Man (ITT4)
NCT01215292 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Insulin Sensitivity in Men With the Metabolic Syndrome
NCT00433173 ·Status: SUSPENDED ·Phase: NA
-
Pharmacokinetic Study to Determine Time to Steady-state
NCT00911586 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term Safety Study of Intramuscular Injections of 750 mg and 1000 mg Testosterone Undecanoate in Hypogonadal Men
NCT00467870 ·Status: COMPLETED ·Phase: PHASE3
-
Influence of Administration Route of Testosterone on Male Fertility
NCT00705796 ·Status: WITHDRAWN ·Phase: PHASE1
-
Hormone Secretion in Transgender Males
NCT04321551 ·Status: WITHDRAWN ·Phase: PHASE4
-
Effect of Increasing Testosterone on Insulin Sensitivity in Men With the Metabolic Syndrome
NCT00438321 ·Status: TERMINATED ·Phase: PHASE1
-
Efficacy and Safety of Testosterone Nasal Gel for Treating Hypogonadism in Men.
NCT03281187 ·Status: UNKNOWN ·Phase: PHASE3
-
Pharmacokinetic Evaluation of Testosterone Gel (1%)
NCT00193700 ·Status: COMPLETED ·Phase: PHASE1
-
Oral T7 Oral Testosterone in Man
NCT00842751 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of Estradiol Addback
NCT01862835 ·Status: COMPLETED ·Phase: PHASE1
-
A Comparison of Side Effects in Hypogonadal Men Treated With Natesto Versus Testosterone Injections
NCT04439799 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetics, Pharmacodinamic and Safety of Testosterone Gel 1%
NCT02667561 ·Status: WITHDRAWN ·Phase: PHASE1
-
Testosterone Gel Applied to Women With Pituitary Gland Problems
NCT00144391 ·Status: COMPLETED ·Phase: PHASE4
-
Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer
NCT00853697 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Daily Application of Nestorone® (NES) and Testosterone (T) Combination Gel for Male Contraception
NCT03452111 ·Status: COMPLETED ·Phase: PHASE2